Hide Board Information

Show Board Information

MetaWorks Platforms Inc. MWRK

Board Mod: Add me as mod

Asst Mods:

Last Post: 11/04/2024 5:34:34 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 3

MetaWorks Platforms Inc. (OTCMRKTS: MWRK) Stock Message Board

1. MWRK Company Profile

    

2. MWRK Time & Sales

    

3. MWRK Recent News

    

4. MWRK Filings

    

5. MWRK Financials

    

6. MWRK Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

9	MWRK Name/Symbol Change, 11/5/2024: from	Steel Reserve	11/04/2024 5:34:34 PM
8	CWRK 22% v2,0M c2.69 f48,2M H2.88	znewcar1	03/31/2021 4:49:47 PM
7	CWRK 43% v3,4M c3.46 f47M	znewcar1	03/17/2021 4:42:35 PM
6	CWRK 25% v2,8M c2.24 f47M H2.31	znewcar1	03/10/2021 5:23:32 PM
5	CWRK 43% v1,6M c1.78 f47,0M H1.78 nice	znewcar1	03/09/2021 4:45:09 PM
4	CWRK 32% v1,7M c.201 f34,9M H.21	znewcar1	12/22/2020 5:19:18 PM
3	CWRK 22% v1,2M c.13 f34,9M	znewcar1	12/16/2020 9:18:18 PM
2	CWRK 58% v5,8M c.1957 f34,9M H.2417	znewcar1	12/04/2020 4:22:57 PM
1	CWRK 218% v8,0M c.1235 f34,9M H.1635	znewcar1	12/03/2020 4:09:49 PM

Recent Articles

• Opportunity for Wolfspeed Investors to Pursue Class Action
• Kyverna Therapeutics Investors Alert Over Recent Class Action
• Marqeta Inc. SEC Class Action Lawsuit: What Investors Need to Know
• Urgent Alert for Symbotic Investors Regarding Class Action
• Investors Reminded of Key Deadline in PACS Group Lawsuits
• Crucial Update for Five9 Investors: Lawsuit Deadline Approaching
• Important Update for Rentokil Investors on Class Action Lawsuit
• Important Update for Match Group Investors: Legal Actions Ahead
• Investors Urged to Act in Zeta Global Class Action Case
• Celsius Holdings Investors: Important Litigation Updates
• ASML Holding Class Action: Important Update for Investors
• Deadline Approaches for Hasbro Shareholders in Class Action
• Critical Update for Toronto-Dominion Bank Investors in Class Action
• Investors of Kyverna Therapeutics Can Pursue Class Action
• Xi Jinping Supports Hong Kong's Economic Strategies and Development
• Solar Alliance Energy Gains Shareholder Approval in Key Meeting
• Fruit Street Health Enhances Diabetes Prevention with Meals
• CNOOC Limited Partners with INEOS Energy in New Agreement
• Exciting Collaboration: Celebrate Japan's Fruit Culture
• Investors Urged to Act Before Deadline in Xiao-I Class Action
• Karma Sauce Applauds First We Feast's Bold New Direction
• Cassava Sciences Investors Encouraged to Act on Stock Losses
• Investors Warned of Upcoming Deadline in WM Technology Case
• Investors Urged to Act: Acadia Healthcare Class Action Deadline
• Aehr Test Systems Faces Class Action, Investors Urged to Act Soon
• Investors Alert: Upcoming Lead Plaintiff Motion Deadline for CUBI
• Legal Action Announced for Five9, Inc. Investors Following Stock Decline
• Legal Action Launched for Kyverna Therapeutics Investors
• Everlight Solar's Culture: A Testament to Team Camaraderie and Growth
• Haloid Enhances Safety in Film Productions with Reviews
• Insights on the Growing Demand for Edible Coatings in Produce
• Prospect Ridge Resources Adjusts Plans for Upcoming Meeting
• Legal Update: Toronto-Dominion Bank Securities Class Action
• Key Updates from Nasdaq on the Nasdaq-100 Index Changes
• TeraBox Revolutionizes File Sharing with Free Unlimited Service
• Kessler Topaz Takes Action Against Enphase Energy for Fraud
• Demesne Resources Completes Second Tranche of Financing
• Spiro Celebrated as One of the Top Agencies in Marketing
• Global Uranium Corp. Launches Strategic Marketing Efforts
• UnitedHealth Group Clarifies Misconceptions and Updates Claims
• Neurocrine Biosciences Unveils Potential of CRENESSITY™ for CAH
• Acadia Healthcare Investors Urged to Take Action on Lawsuit
• Global Uranium Corp. Unveils C$1.5 Million Flow-Through Offering
• Rakovina Therapeutics Secures $3M to Propel Cancer Therapy Advances
• Hola Prime's Innovative Vision: New Marketing Director Appointed
• Teamsters Advocate for Stronger Standards on Autonomous Vehicles
• BioVaxys Secures Funding and Enters Debt Settlement Agreement
• Exciting Advancement as UNLOXCYT Gains FDA Approval for Treatment
• OFS Credit Company Shares November Net Asset Value Insights
• New FDA Approval for Crenessity Enhances CAH Treatment Options